Back
HFA Premium Access

Acute changes in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Doctor K. Docherty (Glasgow, GB)
Event: Heart Failure 2021

Congress Presentation

About the speaker

Doctor Kieran Docherty

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

9 more presentations in this session

Blood pressure response and safety outcomes with vericiguat in the VICTORIA trial

Speaker: Doctor C. Lam (Singapore, SG)

Access
Abstract
Slides
Video
Thumbnail

Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiovascular and non-cardiovascular mortality

Speaker: Ms A. Shahim (Stockholm, SE)

Access
Abstract
Slides
Video
Thumbnail

The impact of multimorbidity on mortality in heart failure with reduced ejection fraction (HFrEF): Which comorbidities matter most?

Speaker: Doctor P. Dewan (Glasgow, GB)

Access
Abstract
Slides
Video
Thumbnail

Clinical outcome predictions for the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial

Speaker: Doctor R. Mentz (Durham, US)

Access
Abstract
Slides
Video
Thumbnail

Features of changes in the level of profibrotic factors and their relationship with parameters of left ventricular mechanics in epicardial obesity

Speaker: Doctor O. Gritsenko (Barnaul, RU)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Chronic Heart Failure - Pathophysiology and Mechanisms 2

Speakers: Doctor K. Docherty, Doctor C. Lam, Ms A. Shahim, Doctor P. Dewan, Doctor R. Mentz...
Access
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb